Literature DB >> 32368869

Lenabasum for Skin Disease in Patients With Diffuse Cutaneous Systemic Sclerosis.

Monique Hinchcliff1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32368869      PMCID： PMC7641910          DOI： 10.1002/art.41302

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN： 2326-5191            Impact factor:   10.995


× No keyword cloud information.
  16 in total

1.  Longitudinal evaluation of PROMIS-29 and FACIT-dyspnea short forms in systemic sclerosis.

Authors:  Monique E Hinchcliff; Jennifer L Beaumont; Mary A Carns; Sofia Podlusky; Krishna Thavarajah; John Varga; David Cella; Rowland W Chang
Journal:  J Rheumatol       Date:  2014-11-01       Impact factor: 4.666

Review 2.  The roles of dermal white adipose tissue loss in scleroderma skin fibrosis.

Authors:  Roberta G Marangoni; Theresa T Lu
Journal:  Curr Opin Rheumatol       Date:  2017-11       Impact factor: 5.006

3.  A four-gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosis.

Authors:  G Farina; D Lafyatis; R Lemaire; R Lafyatis
Journal:  Arthritis Rheum       Date:  2010-02

Review 4.  Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation.

Authors:  Ismael Galve-Roperh; Valerio Chiurchiù; Javier Díaz-Alonso; Monica Bari; Manuel Guzmán; Mauro Maccarrone
Journal:  Prog Lipid Res       Date:  2013-09-25       Impact factor: 16.195

Review 5.  Cannabinoids and the immune system: an overview.

Authors:  Radu Tanasescu; Cris S Constantinescu
Journal:  Immunobiology       Date:  2010-01-04       Impact factor: 3.144

6.  The role of inflammatory markers in assessment of disease activity in systemic sclerosis.

Authors:  Laura Ross; Wendy Stevens; Candice Rabusa; Michelle Wilson; Nava Ferdowsi; Jennifer Walker; Joanne Sahhar; Gene-Siew Ngian; Jane Zochling; Janet Roddy; Kathleen Tymms; Gabor Major; Gemma Strickland; Susanna M Proudman; Mandana Nikpour
Journal:  Clin Exp Rheumatol       Date:  2018-09-29       Impact factor: 4.473

7.  Histopathological cutaneous alterations in systemic sclerosis: a clinicopathological study.

Authors:  Jens T Van Praet; Vanessa Smith; Marc Haspeslagh; Nele Degryse; Dirk Elewaut; Filip De Keyser
Journal:  Arthritis Res Ther       Date:  2011-02-28       Impact factor: 5.156

8.  Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature.

Authors:  M R Pokeerbux; J Giovannelli; L Dauchet; L Mouthon; C Agard; J C Lega; Y Allanore; P Jego; B Bienvenu; S Berthier; A Mekinian; E Hachulla; D Launay
Journal:  Arthritis Res Ther       Date:  2019-04-03       Impact factor: 5.156

9.  Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease.

Authors:  Dinesh Khanna; Donald P Tashkin; Christopher P Denton; Elisabetta A Renzoni; Sujal R Desai; John Varga
Journal:  Am J Respir Crit Care Med       Date:  2020-03-15       Impact factor: 21.405

10.  High-throughput quantitative histology in systemic sclerosis skin disease using computer vision.

Authors:  Chase Correia; Seamus Mawe; Shane Lofgren; Roberta G Marangoni; Jungwha Lee; Rana Saber; Kathleen Aren; Michelle Cheng; Shannon Teaw; Aileen Hoffmann; Isaac Goldberg; Shawn E Cowper; Purvesh Khatri; Monique Hinchcliff; J Matthew Mahoney
Journal:  Arthritis Res Ther       Date:  2020-03-14       Impact factor: 5.156
View more
  2 in total

Review 1.  Therapeutic Approaches to Systemic Sclerosis: Recent Approvals and Future Candidate Therapies.

Authors:  Alain Lescoat; David Roofeh; Masataka Kuwana; Robert Lafyatis; Yannick Allanore; Dinesh Khanna
Journal:  Clin Rev Allergy Immunol       Date:  2021-09-01       Impact factor: 10.817

2.  Juvenile Dermatomyositis: New Clues to Diagnosis and Therapy.

Authors:  Lauren M Pachman; Brian E Nolan; Deidre DeRanieri; Amer M Khojah
Journal:  Curr Treatm Opt Rheumatol       Date:  2021-02-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.